Cargando…
Network pharmacological analysis of Xuefu Zhuyu decoction in the treatment of atherosclerosis
Objective: Using a network pharmacological approach, this study will evaluate the effect of Xuefu Zhuyu Decoction in the treatment of atherosclerosis. Methods: The data were imported into the STRING database to construct a protein-protein interaction network, and the network topology was analysed wi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755496/ https://www.ncbi.nlm.nih.gov/pubmed/36532728 http://dx.doi.org/10.3389/fphar.2022.1069704 |
_version_ | 1784851433125838848 |
---|---|
author | Yuan, Jinxia Yan, Fei Li, Wei Yuan, Guoliang |
author_facet | Yuan, Jinxia Yan, Fei Li, Wei Yuan, Guoliang |
author_sort | Yuan, Jinxia |
collection | PubMed |
description | Objective: Using a network pharmacological approach, this study will evaluate the effect of Xuefu Zhuyu Decoction in the treatment of atherosclerosis. Methods: The data were imported into the STRING database to construct a protein-protein interaction network, and the network topology was analysed with the Bisogenet plug-in by Cytoscape 3.7.2. Using the R language Bioconductor platform, Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis for potential targets of Xuefu Zhuyu Decoction in the treatment of atherosclerosis were performed, and import the results were imported into Cytoscape 3.7.2. To map the results and create a KEGG network diagram, we used Cytoscape 3.7.2 for analysis. Results: A total of 91 chemical components and 1320 disease targets were obtained, including 138 cross-targets. TNF, AKT1 and ALB were identified as important targets, and Gene Ontology functional analysis indicated that biological process was the primary cause of oxidative stress. The primary action of molecular function is binding. KEGG has explored and enriched 149 signalling pathways, including the AGE-RAGE signalling system and the TNF signalling network. According to a study involving molecular docking, quercetin and β-carotene have a strong binding affinity for AKT1 and ALB. Conclusion: The potential of Xuefu Zhuyu Decoction to treat atherosclerosis through multiple components and targets provides a way to further study its mechanism. |
format | Online Article Text |
id | pubmed-9755496 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97554962022-12-17 Network pharmacological analysis of Xuefu Zhuyu decoction in the treatment of atherosclerosis Yuan, Jinxia Yan, Fei Li, Wei Yuan, Guoliang Front Pharmacol Pharmacology Objective: Using a network pharmacological approach, this study will evaluate the effect of Xuefu Zhuyu Decoction in the treatment of atherosclerosis. Methods: The data were imported into the STRING database to construct a protein-protein interaction network, and the network topology was analysed with the Bisogenet plug-in by Cytoscape 3.7.2. Using the R language Bioconductor platform, Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis for potential targets of Xuefu Zhuyu Decoction in the treatment of atherosclerosis were performed, and import the results were imported into Cytoscape 3.7.2. To map the results and create a KEGG network diagram, we used Cytoscape 3.7.2 for analysis. Results: A total of 91 chemical components and 1320 disease targets were obtained, including 138 cross-targets. TNF, AKT1 and ALB were identified as important targets, and Gene Ontology functional analysis indicated that biological process was the primary cause of oxidative stress. The primary action of molecular function is binding. KEGG has explored and enriched 149 signalling pathways, including the AGE-RAGE signalling system and the TNF signalling network. According to a study involving molecular docking, quercetin and β-carotene have a strong binding affinity for AKT1 and ALB. Conclusion: The potential of Xuefu Zhuyu Decoction to treat atherosclerosis through multiple components and targets provides a way to further study its mechanism. Frontiers Media S.A. 2022-12-02 /pmc/articles/PMC9755496/ /pubmed/36532728 http://dx.doi.org/10.3389/fphar.2022.1069704 Text en Copyright © 2022 Yuan, Yan, Li and Yuan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Yuan, Jinxia Yan, Fei Li, Wei Yuan, Guoliang Network pharmacological analysis of Xuefu Zhuyu decoction in the treatment of atherosclerosis |
title | Network pharmacological analysis of Xuefu Zhuyu decoction in the treatment of atherosclerosis |
title_full | Network pharmacological analysis of Xuefu Zhuyu decoction in the treatment of atherosclerosis |
title_fullStr | Network pharmacological analysis of Xuefu Zhuyu decoction in the treatment of atherosclerosis |
title_full_unstemmed | Network pharmacological analysis of Xuefu Zhuyu decoction in the treatment of atherosclerosis |
title_short | Network pharmacological analysis of Xuefu Zhuyu decoction in the treatment of atherosclerosis |
title_sort | network pharmacological analysis of xuefu zhuyu decoction in the treatment of atherosclerosis |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755496/ https://www.ncbi.nlm.nih.gov/pubmed/36532728 http://dx.doi.org/10.3389/fphar.2022.1069704 |
work_keys_str_mv | AT yuanjinxia networkpharmacologicalanalysisofxuefuzhuyudecoctioninthetreatmentofatherosclerosis AT yanfei networkpharmacologicalanalysisofxuefuzhuyudecoctioninthetreatmentofatherosclerosis AT liwei networkpharmacologicalanalysisofxuefuzhuyudecoctioninthetreatmentofatherosclerosis AT yuanguoliang networkpharmacologicalanalysisofxuefuzhuyudecoctioninthetreatmentofatherosclerosis |